PAUL V MAIER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL V MAIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL V MAIER. PAUL V MAIER is Sr. V-P, CFO in LIGAND PHARMACEUTICALS INC ($LGND) and Director in APRICUS BIOSCIENCES, INC. ($APRI) and in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in International Stem Cell CORP ($ISCO) and Director in RITTER PHARMACEUTICALS INC ($RTTR) and Director in Eton Pharmaceuticals, Inc. ($ETON).
Latest Insider Trading Transactions of PAUL V MAIER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETON, ISCO, LGND, MBVX, RTTR, SEEL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2020 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.08 | 30,000 | 32,400 | 30,000 | |
Jun 24 2020 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.08 | 46,428 | 50,142 | 46,428 | |
Mar 16 2020 | ETON | Eton Pharmaceutica ... | MAIER PAUL V | Director | Option Exercise | A | 3.58 | 27,400 | 98,092 | 27,400 | |
Jan 17 2020 | RTTR | RITTER PHARMACEUTI ... | MAIER PAUL V | Director | Option Exercise | A | 0.23 | 12,000 | 2,760 | 12,000 | |
Jun 05 2019 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.08 | 30,000 | 32,400 | 30,000 | |
Jun 05 2019 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.08 | 30,000 | 32,400 | 30,000 | |
Jun 05 2019 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.08 | 71,982 | 77,741 | 71,982 | |
Jun 05 2019 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.08 | 71,982 | 77,741 | 71,982 | |
Apr 22 2019 | ISCO | International Stem ... | MAIER PAUL V | Director | Sell | S | 1.25 | 1,350 | 1,681 | 31,710 | 33.1 K to 31.7 K (-4.08 %) |
Mar 08 2019 | ETON | Eton Pharmaceutica ... | MAIER PAUL V | Director | Option Exercise | A | 7.31 | 12,500 | 91,375 | 12,500 | |
Nov 15 2018 | ETON | Eton Pharmaceutica ... | MAIER PAUL V | Director | Buy | P | 6.00 | 5,000 | 30,000 | 59,745 | 54.7 K to 59.7 K (+9.13 %) |
Jun 25 2018 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.66 | 30,000 | 49,800 | 30,000 | |
Jun 25 2018 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.66 | 38,462 | 63,847 | 38,462 | |
Jun 25 2018 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.66 | 8,655 | 14,367 | 8,655 | |
Apr 03 2018 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.47 | 11,054 | 16,249 | 11,054 | |
Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | MAIER PAUL V | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | MAIER PAUL V | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Sell | S | 0.84 | 17,999 | 15,119 | 68,314 | 86.3 K to 68.3 K (-20.85 %) | |
Jan 24 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Sell | S | 0.87 | 17,449 | 15,181 | 86,313 | 103.8 K to 86.3 K (-16.82 %) | |
Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | M | 0.00 | 100,000 | 0 | 1,543 | ||
Jan 12 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Buy | M | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K | |
Jan 08 2018 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Option Exercise | A | 2.11 | 35,000 | 73,850 | 35,000 | |
Jan 02 2018 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.60 | 10,350 | 16,560 | 10,350 | |
Oct 04 2017 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 0.00 | 75,790 | 0 | 75,790 | ||
Oct 02 2017 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.80 | 8,830 | 15,894 | 8,830 | |
Sep 18 2017 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 0.00 | 24,210 | 0 | 24,210 | ||
Jun 14 2017 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 1.57 | 20,000 | 31,400 | 20,000 | ||
Jun 02 2017 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 1.10 | 30,000 | 33,000 | 30,000 | |
May 23 2017 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 1.80 | 50,000 | 90,000 | 50,000 | ||
Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | M | 0.00 | 1,543 | 0 | 1,543 | ||
Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Buy | M | 0.00 | 1,543 | 0 | 3,762 | 2.2 K to 3.8 K (+69.54 %) | |
Apr 03 2017 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 4,642 | 0 | 33,060 | 28.4 K to 33.1 K (+16.33 %) |
Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Grant | A | 0.00 | 11,250 | 0 | 13,854 | 2.6 K to 13.9 K (+432.03 %) |
Jan 03 2017 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 3.38 | 4,100 | 13,858 | 4,100 | ||
Dec 30 2016 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 7,523 | 0 | 28,418 | 20.9 K to 28.4 K (+36.00 %) |
Nov 30 2016 | RTTR | RITTER PHARMACEUTI ... | MAIER PAUL V | Director | Option Exercise | A | 2.37 | 7,000 | 16,590 | 7,000 | |
Oct 14 2016 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 1,334 | 0 | 20,895 | 19.6 K to 20.9 K (+6.82 %) |
Oct 03 2016 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Grant | A | 0.34 | 10,715 | 3,625 | 26,039 | 15.3 K to 26 K (+69.92 %) |
Sep 30 2016 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 4,391 | 0 | 19,561 | 15.2 K to 19.6 K (+28.95 %) |
Aug 30 2016 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 5.00 | 4,100 | 20,500 | 4,100 | ||
Jul 28 2016 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 0.55 | 35,000 | 19,250 | 35,000 | ||
Jul 01 2016 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Grant | A | 0.40 | 9,074 | 3,625 | 15,324 | 6.3 K to 15.3 K (+145.18 %) |
Jun 30 2016 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 4,042 | 0 | 15,170 | 11.1 K to 15.2 K (+36.32 %) |
May 18 2016 | ISCO | International Stem ... | MAIER PAUL V | Director | Option Exercise | A | 2.30 | 30,000 | 69,000 | 30,000 | |
Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | M | 0.00 | 11,417 | 0 | 22,833 | ||
Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Buy | M | 0.00 | 11,417 | 0 | 16,417 | 5 K to 16.4 K (+228.34 %) | |
Apr 04 2016 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 2,104 | 0 | 11,128 | 9 K to 11.1 K (+23.32 %) |
Apr 07 2016 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Grant | A | 0.58 | 6,250 | 3,625 | 6,250 | 0 to 6.3 K |
Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | MAIER PAUL V | Director | Option Exercise | A | 0.97 | 25,000 | 24,250 | 25,000 | |
Dec 31 2015 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 2,403 | 0 | 9,024 | 6.6 K to 9 K (+36.29 %) |
Oct 15 2015 | RTTR | RITTER PHARMACEUTI ... | MAIER PAUL V | Director | Option Exercise | A | 2.25 | 10,000 | 22,500 | 10,000 | |
Oct 02 2015 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 2,011 | 0 | 6,621 | 4.6 K to 6.6 K (+43.62 %) |
Aug 27 2015 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 1.52 | 35,000 | 53,200 | 35,000 | ||
Jul 02 2015 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 181,767 | 0 | 691,449 | 509.7 K to 691.4 K (+35.66 %) |
Jun 02 2015 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Buy | P | 2.30 | 5,000 | 11,500 | 5,000 | 0 to 5 K | |
Apr 08 2015 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 99,946 | 0 | 509,682 | 409.7 K to 509.7 K (+24.39 %) |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Director | Option Exercise | A | 0.00 | 34,250 | 0 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Director | Option Exercise | A | 2.30 | 34,250 | 78,775 | 34,250 | |
Apr 03 2015 | ISCO | International Stem ... | MAIER PAUL V | Director | Grant | A | 0.00 | 76,958 | 0 | 409,736 | 332.8 K to 409.7 K (+23.13 %) |
Jun 03 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | A | 20.70 | 24,212 | 501,188 | 30,000 | |
Jun 03 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | A | 20.70 | 5,788 | 119,812 | 5,788 | |
Jun 02 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 20.35 | 3,000 | 61,050 | 50,929 | 53.9 K to 50.9 K (-5.56 %) |
Jun 02 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 20.37 | 3,000 | 61,110 | 53,929 | 56.9 K to 53.9 K (-5.27 %) |
May 27 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 19.50 | 2,000 | 39,000 | 56,929 | 58.9 K to 56.9 K (-3.39 %) |
May 17 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Sell | S | 17.43 | 4,000 | 69,720 | 58,929 | 62.9 K to 58.9 K (-6.36 %) |
Mar 26 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 11.26 | 2,250 | 25,335 | 0 | |
Mar 26 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 11.26 | 1,687 | 18,996 | 2,250 | |
Mar 26 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 11.26 | 2,250 | 25,335 | 62,476 | 60.2 K to 62.5 K (+3.74 %) |
Mar 26 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 11.26 | 1,687 | 18,996 | 60,226 | 58.5 K to 60.2 K (+2.88 %) |
Mar 24 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 10.06 | 998 | 10,036 | 0 | |
Mar 24 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 10.06 | 749 | 7,532 | 998 | |
Mar 24 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 10.06 | 998 | 10,036 | 58,539 | 57.5 K to 58.5 K (+1.73 %) |
Mar 24 2004 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 10.06 | 749 | 7,532 | 57,541 | 56.8 K to 57.5 K (+1.32 %) |
Nov 21 2003 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Option Exercise | M | 9.10 | 1,643 | 14,951 | 24,607 | |
Nov 21 2003 | LGND | LIGAND PHARMACEUTI ... | MAIER PAUL V | Sr. V-P, CFO | Buy | M | 9.10 | 1,643 | 14,951 | 56,453 | 54.8 K to 56.5 K (+3.00 %) |
Page: 1